Clinical outcome of Pseudomonas aeruginosa eradication
| Pre-eradication | Post-eradication | p-value# | |
| FEV1 % predicted median (range) | 68 (54–82) | 74 (59–89) | 0.549 |
| Exacerbation frequency | 0.011 | ||
| No exacerbations | 6 (10%) | 16 (27%) | |
| One exacerbation | 19 (32%) | 17 (28%) | |
| Two or more exacerbations | 35 (58%) | 27 (45%) | |
| Hospital admissions | 1.000 | ||
| No exacerbations | 40 (67%) | 40 (67%) | |
| One or more exacerbation(s) | 20 (33%) | 20 (33%) |
FEV1: forced expiratory volume in 1 s. #: 12 months pre-eradication versus 12 months post-eradication, analysed with paired t-test for continuous variables and Chi-squared test for categorical variables. Bold indicates statistically significant p-values.